enrofloxacin has been researched along with Bovine Respiratory Disease Complex in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beyi, AF; Coetzee, JF; Dewell, G; Dewell, R; Hawbecker, T; Magnin, G; Mochel, JP; Plummer, PJ; Sahin, O; Slagel, C; Zhang, Q | 1 |
| Altier, C; Jordan, D; Mann, S; Pereira, RV; Siler, JD; Warnick, LD | 1 |
| Berghaus, R; Credille, B; Crosby, S; Giguère, S | 1 |
| Bade, DJ; Brodersen, B; Bryson, WL; Corley, L; Robb, EJ; Rogers, KC; Sturgess, K; Tucker, CM | 1 |
2 trial(s) available for enrofloxacin and Bovine Respiratory Disease Complex
| Article | Year |
|---|---|
Longitudinal effects of enrofloxacin or tulathromycin use in preweaned calves at high risk of bovine respiratory disease on the shedding of antimicrobial-resistant fecal Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Bovine Respiratory Disease Complex; Cattle; Cattle Diseases; Disaccharides; Enrofloxacin; Escherichia coli; Feces; Heterocyclic Compounds; Risk Assessment | 2020 |
Efficacy of tulathromycin or enrofloxacin for initial treatment of naturally occurring bovine respiratory disease in feeder calves.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Bovine Respiratory Disease Complex; Cattle; Colorado; Disaccharides; Enrofloxacin; Fluoroquinolones; Heterocyclic Compounds; Injections, Subcutaneous; Recurrence; Texas; Treatment Outcome; Weight Gain | 2007 |
2 other study(ies) available for enrofloxacin and Bovine Respiratory Disease Complex
| Article | Year |
|---|---|
Comparisons of plasma and fecal pharmacokinetics of danofloxacin and enrofloxacin in healthy and Mannheimia haemolytica infected calves.
Topics: Animals; Anti-Bacterial Agents; Bovine Respiratory Disease Complex; Cattle; Enrofloxacin; Feces; Fluoroquinolones; Mannheimia haemolytica | 2022 |
Comparative efficacy of enrofloxacin to that of tulathromycin for the control of bovine respiratory disease and prevalence of antimicrobial resistance in Mannheimia haemolytica in calves at high risk of developing bovine respiratory disease.
Topics: Animals; Anti-Bacterial Agents; Bovine Respiratory Disease Complex; Cattle; Disaccharides; Double-Blind Method; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Georgia; Heterocyclic Compounds; Incidence; Male; Mannheimia haemolytica; Prevalence; Random Allocation | 2018 |